Evidence map›Paper›PMID 14729984›Full record

ArticleMolecular and cellular biology2004

Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts.

Fukun Guo, Yi Zheng

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Involvement of caveolin-1 in skin diseases.Frontiers in immunology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  9. Article
  10. YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Fukun GuoDivision of Experimental Hematology, Children's Hospital Research Foundation, University of Cincinnati, Cincinnati, Ohio 45229, USA.
Yi Zheng
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · US

Funding

Dbl-like Regulators of Small GTP-binding ProteinsR01GM053943 · NIGMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ZHENG, YI · 1996 to 2008
$2.3M
INTERACTION OF RHO GTPASES WITH REGULATORS AND EFFECTORSR01GM060523 · NIGMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ZHENG, YI · 2000 to 2007
$1.9M
NIGMS NIH HHS GM53943NIGMS NIH HHS GM60523NIGMS NIH HHS R01 GM053943NIGMS NIH HHS R01 GM060523
6 · The paper itself

Abstract

The Rho family GTPases Rac1, RhoA, and Cdc42 function as molecular switches that transduce intracellular signals regulating gene expression and cell proliferation as well as cell migration. p19(Arf) and p53, on the other hand, are tumor suppressors that act both independently and sequentially to regulate cell proliferation. To investigate the functional interaction and cooperativeness of Rho GTPases with the p19(Arf)-p53 pathway, we examined the contribution of Rho GTPases to the gene transcription and cell proliferation unleashed by deletion of p19Arf or p53 in primary mouse embryo fibroblasts. We found that (i) p19(Arf) or p53 deficiency led to a significant increase in PI 3-kinase activity, which in turn upregulated RhoA and Rac1 activities; (ii) deletion of p19Arf or p53 led to an increase in cell growth rate that was in part dependent on RhoA, Rac1, and Cdc42 activities; (iii) p19(Arf) or p53 deficiency caused an enhancement of the growth-related transcription factor NF-kappa B and cyclin D1 activities that are partly dependent on RhoA or Cdc42 but not on Rac1; (iv) forced expression of the activating mutants of Rac1, RhoA, or Cdc42 caused a hyperproliferative phenotype of the p19Arf(-/-) and p53(-/-) cells and promoted transformation of both cells; (v) RhoA appeared to contribute to p53-regulated cell proliferation by modulating cell cycle machinery, while hyperactivation of RhoA further suppressed a p53-independent apoptotic signal; and (vi) multiple pathways regulated by RhoA, including that of Rho-kinase, were required for RhoA to fully promote the transformation of p53(-/-) cells. Taken together, these results provide strong evidence indicating that signals through the Rho family GTPases can both contribute to cell growth regulation by p19Arf and p53 and cooperate with p19Arf or p53 deficiency to promote primary cell transformation.

Indexed as

AnimalsCell DivisionCyclin D1Cyclin-Dependent Kinase Inhibitor p16MiceNF-kappa BPhosphatidylinositol 3-KinasesrhoA GTP-Binding Proteinrho GTP-Binding ProteinsTumor Suppressor Protein p14ARFTumor Suppressor Protein p53Cdkn2a protein, mouseCyclin D1Cyclin-Dependent Kinase Inhibitor p16NF-kappa BPhosphatidylinositol 3-KinasesrhoA GTP-Binding Proteinrho GTP-Binding ProteinsTumor Suppressor Protein p14ARFTumor Suppressor Protein p53

Identifiers

PMID14729984
PMCPMC321455
OpenAlexW2101940144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.